Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Allergy and Clinical Immunology|September 2, 2009
Cytokine modulation of atopic dermatitis filaggrin skin expressionMichael D Howell, Byung Eui Kim, Peisong Gao, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 23, 2025
Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic ComorbiditiesEllen R Sher, Alexandra Golant, Marjolein de Bruin-Weller, et al.
Allergy and Asthma Proceedings|May 16, 2012
Effect of cat and daycare exposures on the risk of asthma in children with atopic dermatitisJonathan M Gaffin, Jonathan M Spergel, Mark Boguniewicz, et al.
Pediatrics|August 5, 2015
Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care ProvidersLawrence F Eichenfield, Mark Boguniewicz, Eric L Simpson, et al.
Pharmacoeconomics|August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczemaCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 14, 2018
Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitisJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging TherapiesMark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
Journal of Drugs in Dermatology : JDD|February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in PracticeMark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical reviewJonathan I Silverberg, Mark Boguniewicz, Francisco J Quintana, et al.
Acta Dermato-Venereologica|October 7, 2021
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Mark Boguniewicz, et al.
Pageof 15